AMCO was instructed by a biotechnology firm focused on gene therapy solutions to value its IP portfolio. The company needed an independent valuation for fundraising purposes as it prepared for clinical trials of its flagship treatment.
We reviewed the firm’s patents, clinical trial data, and proprietary gene-editing technologies. Our valuation accounted for the therapy’s market potential, competitive landscape, and regulatory considerations within gene therapy.
The robust IP valuation enabled the biotech firm to attract major investment, securing funding needed for clinical trials and advancing towards regulatory approval.
London Office
First Floor, 85 Great Portland Street, London, W1W 7LT
New York Office
3rd Floor, 1178 Broadway, New York, NY 10001, United States
Copyright © AMCO AGENCY LTD | All Rights Reserved | Website by Dentify Digital
